8th CML-CAB
CML-CAB 2019 II
8th CML-CAB: Lisbon, Portugal, 16 May 2019
On 16 May 2019, the CML Community Advisory Board (CML-CAB), a workgroup of the CML Advocates Network, hosted its 8th meeting to discuss issues of major concern to the CML community.
CML-CAB Members attending the 8th CML-CAB as patient experts:
- Jan Geissler, Germany (CML-CAB chair)
- Pat Garcia-Gonzalez, USA, The Max Foundation (Co-chair)
- Giora Sharf, Israel (Europe)
- Jana Pelouchova, Czech Republic (Central and Eastern Europe)
- Mercedes Arteaga, Argentina (representing Latin America)
- Gail Sperling, USA (representing North America)
- Bahija Gouimi, Morocco (representing Africa and Middle East)
- Rita Christensen, Denmark (representing Western Europe)
- Rod Padua, Philippines (representing East Asia and Pacific)
- Felice Bombaci, Italy (representing Western Europe)
- Silvia Castillo De Armas, Guatemala (Latin America)
- Sarunas Narbutas, Lithuania (Central & Eastern Europe, & West Asia)
- Lisa Machado, Canada (North America)
- Yair Bar David, Israel
- Cornelia Borowczak, Germany (Paediatrics)
- Zack Pemberton-Whiteley, United Kingdom (Western Europe)
- Jelena Cugurovic, Serbia (Eastern Europe)
- Parameswaran Puthen, India (East Asia/Pacific)
- Eunice Orekha, Nigeria (Africa)
Plus, the CML Advocates Network team Lidija Pecova and Celia Marin.
CML-CAB with Novartis, 16th May 2019, 14:00 – 18:00
The following topics were discussed during the CML-CAB:
- Research
- Access
- Treatment-free remission (TFR)
- Collaboration, discussion and Next Steps
Non-confidential minutes of the meeting are available to CML Advocates Network members below:
pdf 8th CMLCAB May 2019 Novartis Minutes Non-confidential (562 KB)